Page last updated: 2024-11-07

metaraminol and Leukemia, Myeloid

metaraminol has been researched along with Leukemia, Myeloid in 2 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FREIREICH, EJ1
LEVIN, RH1
WHANG, J1
CARBONE, PP1
BRONSON, W1
MORSE, EE1

Other Studies

2 other studies available for metaraminol and Leukemia, Myeloid

ArticleYear
THE FUNCTION AND FATE OF TRANSFUSED LEUKOCYTES FROM DONORS WITH CHRONIC MYELOCYTIC LEUKEMIA IN LEUKOPENIC RECIPIENTS.
    Annals of the New York Academy of Sciences, 1964, Feb-28, Volume: 113

    Topics: Anti-Bacterial Agents; Blood Transfusion; Cell Division; Humans; Leukemia; Leukemia, Myelogenous, Ch

1964
Polycythemia vera complicated by acute leukemia and a rapidly enlarging mass in the left upper abdominal quadrant.
    The American journal of medicine, 1967, Volume: 42, Issue:6

    Topics: Aspirin; Female; Heart Arrest; Humans; Leukemia, Myeloid; Metaraminol; Middle Aged; Polycythemia Ver

1967